Discovery of a new gene in monkeys that could help develop new antiviral drugs
In this interview, we spoke with Dr. Nels Elde about his latest research that led to the discovery of a…
New Delta sublineage shows no further resistance to neutralization
Coronavirus disease 2019 (COVID-19) has caused over five million deaths and has spread to almost every country in the world.…
Initial detection of SARS-CoV-2 remdesivir resistance in an immunocompromised patient
A research group from the USA (led by experts from Yale University School of Medicine) recently presented a case of…
Cell-based viral replication system for screening SARS-CoV-2 drugs
A viral replicon system suitable for stable replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), without cytopathic effects,…
Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China in 2019 and is the cause…
The difference in the dynamics of SARS-COV-2 variants
A new study published on the preprint server bioRxiv * provides a detailed description of the varying interactions between the…
A high-throughput pipeline to identify nanocarbons that target and neutralize SARS-CoV-2
Researchers in the US have developed a cost-effective, high-throughput pipeline to identify effective nanobodies that target and neutralize severe acute…
N501Y mutation in SARS-CoV-2 Delta variant is the key to breakthrough infections
A study in the Philadelphia area showed that variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are evolving to…
Development of a safe and effective COVID-19 nanoparticle vaccine
The coronavirus disease 2019 (COVID-19) has killed over 4.9 million people worldwide. With a rapid transfer rate, few effective therapeutic…
Replication of SARS-CoV-2 variants in different cell and organ models
The emergence of genetically diverse severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with altered phenotypic characteristics has occurred due…